Levomilnacipran Extended-release Capsules 120mg

Levomilnacipran Extended-release Capsules 120mg Technical Specification: 

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Levomilnacipran Extended-release Capsules 20mg
B) Levomilnacipran Extended-release Capsules 40mg
C) Levomilnacipran Extended-release Capsules 80mg
D) Levomilnacipran Extended-release Capsules 120mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Levomilnacipran Extended-release Capsules 20mg
Each hard gelatin capsule contains:
Levomilnacipran Hydrochloride
Equivalent to Levomilnacipran………….20mg
Excipients……………………………………………q.s.
Approved colours used in capsule shells.

B) Levomilnacipran Extended-release Capsules 40mg
Each hard gelatin capsule contains:
Levomilnacipran Hydrochloride
Equivalent to Levomilnacipran…………..40mg
Excipients…………………………………………..q.s.
Approved colours used in capsule shells.

C) Levomilnacipran Extended-release Capsules 80mg
Each hard gelatin capsule contains:
Levomilnacipran Hydrochloride
Equivalent to Levomilnacipran………….80mg
Excipients………………………………………….q.s.
Approved colours used in capsule shells.

D) Levomilnacipran Extended-release Capsules 120mg
Each hard gelatin capsule contains:
Levomilnacipran Hydrochloride
Equivalent to Levomilnacipran…………120mg
Excipients………………………………………….q.s.
Approved colours used in capsule shells.

THERAPEUTIC INDICATIONS:

Levomilnacipran is used to treat depression. Levomilnacipran is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of serotonin and norepinephrine, natural substances in the brain that helps maintain mental balance.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH

Warning: To be sold by retail on the prescription of a Neurologists And Psychiatrist only.

STORAGE & DOSAGE:

Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Dosage: As directed by the Psychiatrist.

Attach dispensing label as per end country.

1. Introduction to Levomilnacipran Extended-release Capsules 120mg: Maximum Strength Efficacy in Depression Management

Levomilnacipran Extended-release Capsules 120mg represent the pinnacle of SNRI therapy for Major Depressive Disorder (MDD), offering the highest available dosage strength for patients requiring maximum pharmacological support. This advanced formulation delivers robust dual reuptake inhibition of serotonin and norepinephrine, with a distinctive pharmacological profile emphasizing greater potency for norepinephrine reuptake blockade. This unique mechanism potentially offers enhanced efficacy for depressive symptoms characterized by fatigue, lack of energy, and cognitive difficulties, which often prove challenging to treat with conventional antidepressants.

The 120mg dosage serves as the maximum therapeutic strength for patients who have demonstrated partial response to lower doses or those with severe, treatment-resistant depressive episodes. The extended-release technology ensures controlled 24-hour drug delivery, maintaining stable plasma concentrations while minimizing peak-trough fluctuations that can contribute to side effects. This sophisticated delivery system represents a significant advancement in maintaining consistent neurotransmitter modulation throughout the dosing interval.

Global Demand and Therapeutic Applications:
The international demand for Levomilnacipran Extended-release Capsules 120mg continues to expand, driven by several critical factors:

• Treatment-Resistant Depression: Growing recognition of treatment-resistant depression and the need for optimized dosing strategies in specialized patient populations.

• Severe MDD Management: Essential role in managing severe depressive episodes where rapid and robust symptom control is clinically imperative.

• Step-up Therapy: Strategic use in dose escalation protocols for patients showing partial response to lower antidepressant doses.

• Advanced Mental Health Systems: Increasing adoption in healthcare systems with sophisticated depression treatment algorithms and specialized mental health services.

This specialized global demand underscores the necessity for a highly reliable and quality-focused Levomilnacipran Extended-release Capsules 120mg Supplier capable of maintaining stringent quality standards for high-potency formulations.

2. A Buyer’s Guide: Essential Details for Importers & Distributors

Procuring maximum-strength antidepressant formulations requires a manufacturer with advanced technological capabilities, robust quality systems, and comprehensive regulatory expertise. Taj Pharma is systematically structured to provide a seamless and reliable sourcing experience for international partners requiring high-potency psychiatric medications.

➤ Regulatory Documentation and Compliance

We provide a complete suite of documentation to facilitate smooth market entry and regulatory compliance for maximum-strength formulations:

• Certificate of Pharmaceutical Product (COPP): Issued in accordance with WHO specifications with emphasis on high-potency manufacturing controls.

• WHO-GMP Certificate: Our manufacturing facility maintains full compliance with WHO Good Manufacturing Practices for potent drug products.

• EU-GMP Compliance: Our plant is designed and operated to meet stringent European Good Manufacturing Practice standards for high-strength formulations.

• Certificate of Analysis (CoA): Batch-specific documentation providing comprehensive analytical results including assay, related substances, dissolution profile, and content uniformity.

• CTD Dossier: Complete Common Technical Document prepared for regulatory submissions with detailed manufacturing process validation for high-strength products.

• Stability Studies Data: Extensive data supporting the product’s shelf life under recommended storage conditions.

➤ Custom Packaging & Labeling

We offer specialized packaging solutions tailored to the requirements of high-potency psychiatric medications:

• High-Barrier Blister Packing: Alu-Alu blister packs with superior moisture protection and enhanced child-resistant features.

• Security-Enhanced Bottle Packaging: HDPE bottles with induction seals, tamper-evident closures, and desiccant canisters.

• Strength Identification: Clear, prominent labeling with specific high-strength identification to prevent medication errors.

• Comprehensive Leaflets: Detailed patient information leaflets with specific guidance for maximum-strength antidepressant therapy.

➤ Shelf-Life, Storage, and Dosage Form

• Dosage Form: Extended-release capsules for controlled drug delivery of high-potency formulation.

• Shelf-Life: 24 months from the date of manufacture when stored under recommended conditions.

• Storage Conditions: Store at controlled room temperature 20-25°C (68-77°F). Protect from moisture and light. Maintain in original packaging with secure closure.

➤ Target Export Markets & Certifications

3. Why Taj Pharma is the Most Trusted Levomilnacipran 120mg Manufacturer & Exporter

Selecting Taj Pharma for maximum-strength antidepressant manufacturing means partnering with an organization where technological innovation, quality excellence, and regulatory compliance are integrated into our core operational philosophy.

➤ State-of-the-Art Manufacturing & Quality Systems

Our advanced manufacturing facility in Vapi features specialized containment and processing equipment for high-potency drug manufacturing. We employ sophisticated technologies including precision powder handling systems, controlled-release formulation expertise, and comprehensive cleaning validation protocols to prevent cross-contamination.

➤ Competitive Pricing & Quality Commitment

Through manufacturing excellence and operational efficiency, we offer Levomilnacipran Extended-release Capsules 120mg at competitive prices while maintaining the highest quality standards for high-strength formulations. This enables access to advanced antidepressant therapy while providing our partners with sustainable commercial advantages.

➤ Global Supply Chain & Regulatory Expertise

Our experienced regulatory and logistics teams ensure seamless international distribution of high-potency medications with complete documentation support. We maintain established relationships with global freight partners specializing in pharmaceutical products and provide comprehensive regulatory guidance for market-specific requirements.

4. Technical Product Specification Table

5.  Call to Action:  

Choosing the right manufacturing partner for maximum-strength antidepressant medications is crucial for ensuring consistent supply of high-quality mental health treatments for severe depression. Taj Pharma offers a partnership built on manufacturing excellence, regulatory expertise, and shared commitment to advancing global mental healthcare.

Contact Taj Pharma today to discuss your specific requirements for high-potency antidepressant medications, request a competitive quotation, or obtain samples and comprehensive product documentation. Let us be your trusted partner for advanced psychiatric pharmaceuticals.

Contact Taj Pharma

Head Office:
Tel. No.: +91 – 22 – 2637 4592 / 2637 4593 (IST)
Fax: +91 – 22 – 2634 1274
Gen. Enquiry: +91 84484 44095

WhatsApp Support:
Mobile: +91 74 0000 9975 / +91 74 0000 9976

Email: info@tajpharma.com

6. Top 20 FAQs  

1. What is the specific indication for the 120mg strength?
It is indicated for the treatment of Major Depressive Disorder in adults who require the maximum therapeutic dose for adequate symptom control.

2. Who is the licensed manufacturer of this maximum strength?
Taj Pharma Ltd. is a leading Levomilnacipran Extended-release Capsules 120mg Manufacturer in India with all necessary regulatory approvals.

3. How does the 120mg strength differ from lower doses?
It provides maximum dual reuptake inhibition of serotonin and norepinephrine, offering the highest level of pharmacological activity in the dosing range.

4. What is the appropriate patient population for this strength?
Typically reserved for patients with inadequate response to lower doses or those with severe, treatment-resistant depression under close medical supervision.

5. What enhanced monitoring is required at this dose?
More frequent assessment of blood pressure, heart rate, and emergence of suicidal ideation, particularly during initial therapy and dose adjustments.

6. Do you provide specialized documentation for high-strength products?
Yes, we supply comprehensive documentation including enhanced manufacturing controls and potency verification data.

7. What is your minimum order quantity for the 120mg strength?
We offer flexible MOQs while maintaining the specialized manufacturing requirements for high-potency products.

8. How is product quality ensured for maximum-strength formulations?
Through enhanced process validation, rigorous content uniformity testing, and comprehensive cleaning verification between batches.

9. Can you supply to markets with stringent high-potency regulations?
Yes, we have capability and experience supplying to highly regulated markets with specific requirements for potent drug manufacturing.

10. What is the shelf life for this maximum strength formulation?
We provide a 24-month shelf life from the date of manufacture when stored under recommended conditions.

11. Are there specific administration considerations at this dose?
Should be administered once daily, swallowed whole, and typically requires gradual dose titration to minimize initial side effects.

12. Do you offer PCD Pharma Franchise for specialized strengths?
We work with qualified distributors who demonstrate capability in handling and promoting specialized psychiatric medications.

13. What is your manufacturing capacity for high-strength formulations?
We have dedicated production lines with enhanced engineering controls specifically designed for high-potency manufacturing.

14. How do you ensure consistent drug release at maximum strength?
Through validated extended-release technology and rigorous in-process controls for dissolution and release characteristics.

15. What additional safety data is available for the 120mg dose?
We can provide comprehensive safety and tolerability data from clinical studies and post-marketing experience.

16. What are the dose-dependent side effects?
Higher incidence of noradrenergic side effects including increased heart rate, blood pressure changes, and excessive sweating.

17. How should treatment be initiated and titrated?
Typically initiated at lower doses with gradual upward titration based on clinical response and tolerability assessment.

18. What are the specific storage requirements?
Store at controlled room temperature, protected from moisture and light, in original packaging with secure closure.

19. Are there specific contraindications at this dose?
Use with caution in patients with uncontrolled hypertension, cardiac conditions, or substantial renal impairment.

20. How can qualified institutional buyers request samples?
Serious distributors and healthcare institutions can request samples through our official channels with appropriate documentation and credentials.